SCHEMBL9367642

SCHEMBL9367642

CCCCc1ncc(/C=C(/Cc2nnn[nH]2)Cc2cccs2)n1Cc1ccccc1Cl

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 2/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9367636 1.00 AGTR1 (0.66) AGTR1
SCHEMBL7448211 0.87 AGTR1 (0.67) AGTR1
SCHEMBL7448217 0.87 AGTR1 (0.67) AGTR1
SCHEMBL7448206 0.87 AGTR1 (0.67) AGTR1
SCHEMBL7278018 0.86 AGTR1 (0.75) AGTR1
SCHEMBL7278024 0.86 AGTR1 (0.75) AGTR1
SCHEMBL9374713 0.85 AGTR1 (0.49) AGTR1
SCHEMBL9374698 0.85 AGTR1 (0.49) AGTR1
SCHEMBL9374706 0.85 AGTR1 (0.49) AGTR1
SCHEMBL9367432 0.85 AGTR1 (0.65) AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0425211-B1 Substituted 5-((tetrazolyl)alkenyl)-imidazoles SMITHKLINE BEECHAM CORP (US) 1994-03-30 EP disclosed
US-5177096-A Angiotensin II receptor antagonist SMITHKLINE BEECHAM CORPORATION (US) 1993-01-05 US disclosed